Bitdeer Technologies
BTDR
Mawson Infrastructure
MIGI
Digihost Technology
DGHI
Canaan
CAN
Intchains Group
ICG
Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. The Pharmaceutical Compounding segment focuses on the operations of the ImprimisRx business. The company was founded by Mark L. Baum and Robert J. Kammer in January 2006 and is headquartered in Nashville, TN.